0001181431-12-041552.txt : 20120720
0001181431-12-041552.hdr.sgml : 20120720
20120720165921
ACCESSION NUMBER: 0001181431-12-041552
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120709
FILED AS OF DATE: 20120720
DATE AS OF CHANGE: 20120720
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Norton David Y
CENTRAL INDEX KEY: 0001529193
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-15313
FILM NUMBER: 12972824
MAIL ADDRESS:
STREET 1: ONE TOWER CENTER BLVD.
CITY: EAST BRUNSWICK
STATE: NJ
ZIP: 08816
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SAVIENT PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000722104
STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
IRS NUMBER: 133033811
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE TOWER CENTER
CITY: EAST BRUNSWICK
STATE: NJ
ZIP: 08816
BUSINESS PHONE: 7324189300
MAIL ADDRESS:
STREET 1: ONE TOWER CENTER
CITY: EAST BRUNSWICK
STATE: NJ
ZIP: 08816
FORMER COMPANY:
FORMER CONFORMED NAME: BIO TECHNOLOGY GENERAL CORP
DATE OF NAME CHANGE: 19920703
4
1
rrd351432.xml
FORM 4
X0306
4
2012-07-09
0
0000722104
SAVIENT PHARMACEUTICALS INC
SVNT
0001529193
Norton David Y
ONE TOWER CENTER BLVD.
FLOOR 14
EAST BRUNSWICK
NJ
08816
1
0
0
0
Common Stock, $0.01 par value
2012-07-09
4
A
0
62035
.56
A
69284
D
Option to purchase The right to receive these shares is purs
.56
2012-07-09
4
A
0
82458
.56
D
2012-08-22
2022-07-09
Common Stock, $0.01 par value
82458
82458
D
The right to receive these shares is pursuant to a restricted stock unit grant, 100% of which shall vest 30 days from the first anniversary of the grant date.
These stock options will vest as follows: 11,481 on August 22, 2012, 23,659 on November 22, 2012, 23,659 on February 22, 2013, and 23,659 on the earlier of May 22, 2013 or the Company's 2013 Annual Meeting of Stockholders.
Irina Ishak as Attorney-In-Fact for David Y. Norton
2012-07-20